Hypertrophic Cardiomyopathy (HCM) is characterized by left ventricular (LV) hypertrophy not attributable to other cardiac, systemic, or metabolic diseases. Traditional treatment options address symptoms, but not the underlying mechanisms of disease. This series examines new and emerging disease-modifying therapies for the management of HCM.
Videos in the Series
Funding support provided by Cytokinetics®.
About CardioBites
CardioBites are mobile-friendly, bite-sized videos providing focused education on important topics in the heart failure field. They can be watched anytime, anywhere on YouTube. No password. No barriers. Just easy access. Each CardioBites series is designed to educate physicians, scientists, nurses, nurse practitioners, pharmacists, and patients about the recent advances and emerging trends in Heart Failure. Learn More.